Use of IGF-1
First Claim
1. Method for treating Type 1 diabetes mellitus by subcutaneously administering to a patient suffering from Type 1 diabetes mellitus, IGF-1 in a dose effective to achieve an IGF-1 serum level of up to 400 ng/ml that is characteristic in healthy individuals.
3 Assignments
0 Petitions
Accused Products
Abstract
The invention relates to the use of IGF-1 for the manufacture of a medicament for treatment of Type 1 diabetes mellitus. the medicament comprising a subcutaneous dose not greater than needed to achieve an IGF-1 serum level characteristic for healthy individuals i.e. a physiological replacement of serum IGF-1. This treatment would be especially valuable for the treatment of children or adolescents with Type 1 diabetes mellitus and could lead to improvements in their pubertal growth.
50 Citations
13 Claims
- 1. Method for treating Type 1 diabetes mellitus by subcutaneously administering to a patient suffering from Type 1 diabetes mellitus, IGF-1 in a dose effective to achieve an IGF-1 serum level of up to 400 ng/ml that is characteristic in healthy individuals.
Specification